| Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 353show all (up to 200) |
|---|
| → investigated in trials for | Cisplatinsmall molecule 361 trials (132 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 361 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 329 trials (155 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 329 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 328 trials (111 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 328 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 283 trials (112 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 283 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 214 trials (90 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 214 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 211 trials (83 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 211 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 188 trials (13 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 188 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall_molecule 186 trials (60 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 186 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 183 trials (55 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 183 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 153 trials (64 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 153 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 148 trials (44 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 148 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 146 trials (45 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 146 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 139 trials (52 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 139 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 129 trials (68 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 129 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 124 trials (69 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 124 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 114 trials (39 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 114 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 111 trials (41 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 111 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 99 trials (25 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 99 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall_molecule 98 trials (28 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 98 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 97 trials (30 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 97 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 85 trials (42 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 85 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 82 trials (26 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 82 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 78 trials (37 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 78 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 75 trials (37 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 75 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 75 trials (41 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 75 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 73 trials (30 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 73 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 72 trials (28 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 72 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 68 trials (35 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 68 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 61 trials (32 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 60 trials (19 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 60 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall_molecule 53 trials (17 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 52 trials (30 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 50 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 49 trials (22 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abiraterone Acetatesmall molecule 48 trials (20 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 44 trials (21 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 43 trials (10 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 43 trials (12 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 41 trials (26 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 37 trials (16 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 37 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 35 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leuprolideother 34 trials (16 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 33 trials (25 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 32 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 30 trials (7 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 28 trials (14 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Apalutamidesmall molecule 26 trials (17 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Goserelinother 26 trials (12 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall_molecule 26 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall_molecule 25 trials (7 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 24 trials (7 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 23 trials (11 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 23 trials (7 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 22 trials (10 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 22 trials (6 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 21 trials (8 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 20 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 18 trials (8 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 18 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 18 trials (6 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 18 trials (6 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 18 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 17 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 17 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 17 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 17 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 16 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Darolutamidesmall molecule 16 trials (13 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Degarelixother 16 trials (10 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Vipivotide Tetraxetanother 16 trials (11 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 16 trials (6 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 16 trials (11 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 16 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 15 trials (11 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 15 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 15 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 15 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall_molecule 15 trials (6 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 14 trials (9 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 14 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 13 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 11 trials (9 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Flutamidesmall_molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nedaplatinsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Relugolixsmall molecule 9 trials (8 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Icotinibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Triptorelinother 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | CAPOX Regimen 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX-4 Regimen 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitotanesmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ivosidenibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selpercatinibsmall molecule 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tegafursmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Encorafenibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Histrelinother 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Infigratinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onartuzumabmonoclonal antibody 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralsetinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tivozanibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinfluninesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall_molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anastrozolesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brigatinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganitumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hormone Therapy 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linsitinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lorlatinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Oxodotreotideother 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall_molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxel Liposome 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Savolitinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarlatamabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Estramustinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Firmonertinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futuximab/Modotuximab Mixture 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hyperthermic Intraperitoneal Chemotherapy 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Levoleucovorinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma | 3 | Observed | clinicaltrials | graph → |